Immunovia AB (publ) (FRA:1YR)
Germany · Delayed Price · Currency is EUR 0.0039
-0.0012 (-23.53%)
At close: Nov 28, 2025
Immunovia AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Operating Revenue | 0.79 | 0.93 | 1.58 | 1.15 | 0.84 | 0.36 | Upgrade |
| 0.79 | 0.93 | 1.58 | 1.15 | 0.84 | 0.36 | Upgrade | |
Revenue Growth (YoY) | 24.37% | -40.89% | 37.55% | 35.66% | 133.15% | 1.69% | Upgrade |
Cost of Revenue | 0.04 | - | 6.68 | 4.21 | -14.97 | -40.02 | Upgrade |
Gross Profit | 0.75 | 0.93 | -5.11 | -3.07 | 15.81 | 40.38 | Upgrade |
Selling, General & Admin | 91.08 | 94.48 | 148.3 | 162.97 | 162.09 | 165.12 | Upgrade |
Other Operating Expenses | 0.98 | 3.21 | 1.56 | 0.26 | 1.4 | 0.18 | Upgrade |
Operating Expenses | 95 | 111.11 | 291.58 | 188.14 | 182.55 | 175.06 | Upgrade |
Operating Income | -94.25 | -110.17 | -296.69 | -191.21 | -166.74 | -134.68 | Upgrade |
Interest Expense | -64.64 | -1.86 | -1.17 | -1.6 | -1.43 | -1.42 | Upgrade |
Interest & Investment Income | 33.25 | 34.73 | 6.28 | 0.75 | 0.71 | 0.58 | Upgrade |
Currency Exchange Gain (Loss) | 0.76 | 0.76 | -17.87 | 23.97 | 11.5 | -10.51 | Upgrade |
Other Non Operating Income (Expenses) | -0.64 | - | 0.01 | - | - | - | Upgrade |
EBT Excluding Unusual Items | -125.52 | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade |
Pretax Income | -125.52 | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade |
Net Income | -125.52 | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade |
Net Income to Common | -125.52 | -76.54 | -309.44 | -168.09 | -155.97 | -146.03 | Upgrade |
Shares Outstanding (Basic) | 245 | 83 | 39 | 23 | 23 | 21 | Upgrade |
Shares Outstanding (Diluted) | 245 | 83 | 39 | 23 | 23 | 21 | Upgrade |
Shares Change (YoY) | 347.58% | 112.20% | 72.02% | - | 6.05% | 9.05% | Upgrade |
EPS (Basic) | -0.51 | -0.93 | -7.95 | -7.43 | -6.89 | -6.84 | Upgrade |
EPS (Diluted) | -0.52 | -0.93 | -7.95 | -7.43 | -6.89 | -6.84 | Upgrade |
Free Cash Flow | -86.89 | -96.75 | -147.06 | -176.84 | -155.75 | -124.7 | Upgrade |
Free Cash Flow Per Share | -0.35 | -1.17 | -3.78 | -7.81 | -6.88 | -5.84 | Upgrade |
Gross Margin | 95.42% | 100.00% | - | -267.77% | 1873.58% | 11155.25% | Upgrade |
Operating Margin | -11990.46% | -11833.94% | -18837.27% | -16699.48% | -19756.04% | -37203.87% | Upgrade |
Profit Margin | -15968.96% | -8221.38% | -19646.92% | -14680.52% | -18479.38% | -40340.61% | Upgrade |
Free Cash Flow Margin | -11055.22% | -10392.37% | -9336.95% | -15444.37% | -18453.67% | -34448.07% | Upgrade |
EBITDA | -90.97 | -96.42 | -170.03 | -185.15 | -161.1 | -130.41 | Upgrade |
D&A For EBITDA | 3.27 | 13.75 | 126.66 | 6.06 | 5.64 | 4.27 | Upgrade |
EBIT | -94.25 | -110.17 | -296.69 | -191.21 | -166.74 | -134.68 | Upgrade |
Revenue as Reported | 0.91 | 1.69 | 1.8 | 1.2 | 0.96 | 0.99 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.